OpenHDI · Open Health Data Impact

Assessing the clinical- and cost-effectiveness of REFUEL-MS, a digital therapeutic for multiple sclerosis-related fatigue: study protocol for a randomised controlled trial.

Research paper from Europe PMC. Evidence status: source reported.

Published
2026-08-11
Source reference
MED:43000399
DOI
10.1186/s13063-026-09925-8
Jurisdiction
Not assessed
Licence
Bibliographic metadata only; article rights retained

Fawson S, Mortimer H, Abouzahr A, Proudfoot H, Ibrahimi E, Dodsworth N, Jackson T, Milne-Ives M, REFUEL-M. S. Patient Advisory Group, Sanders T, Finch T, Thomas S, Freeman J, van der Linden ML, Mercer T, Williams V, Barrett B, Norton S, Moss-Morris R. · Trials · clinical trial protocol; research-article; journal article · Found via: CPRD

Source: https://europepmc.org/article/MED/43000399. Captured 2026-11-12.

Limitations: Discovered through a Europe PMC keyword search for CPRD. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.